Sella et al.
N, 14.6. IR (KBr pellet, cm-1): 3138 w, 3098 w, 2970 m, 2919
m, 2874 m, 1564 s, 1458 s, 1415 m, 1381 m, 1305 s, 1266 s, 1108
w, 1039 s, 980 w, 906 m, 861 s, 82 m, 806 m, 794 m, 707 sh, 482
w. The compound was NMR silent.
1038 m, 979 w, 906 w, 859 m, 800 w, 759 m, 746 m, 705 s, 531.
1H NMR (CD2Cl2, 300 MHz, 293 K): δ 1.95 (s, 18H, Me-OAr),
2.06 (s, 9H, 3- or 5-Me), 2.58 (s, 9H, 3- or 5-Me), 5.94 (s, 3H,
Tpm 4-CH), 6.31 (t, J ) 7.2 Hz, 3H, OAr p-H), 6.78 (d, J ) 7.2
Hz, 6H, OAr m-H), 8.05 (s, 1H, Tpm C-H). 13C{1H} NMR (CD2-
Cl2, 75.44 MHz, 293 K): δ 11.48 (OArMe), 13.28 (3- or 5-Me),
17.59 (3- or 5-Me), 68.75 (Tpm CH), 107.94 (Tpm 4-CH), 114.54
(p-OAr), 126.60 (2-C-OAr), 127.76 (m-OAr), 140.00 (5-C Tpm*),
155.12 (3-C Tpm*), 162.89 (d, JYC ) 5.4 Hz, ipso-OAr).
[Yb(Tpm*)Cl3], 1f. The reaction was carried out in THF
analogous to the procedure describe for 1a using YbCl3 (94 mg,
3.4 mmol) and Tpm* (100 mg, 3.4 mmol) to afford Yb(Tpm*)Cl3
as a cream-colored, THF-insoluble powder. Yield: 124 mg (64%).
Anal. Calcd for C16H22N6Cl3Yb: C, 33.3; H, 3.8; N, 14.5. Found:
C, 33.6; H, 3.7; N, 14.2. IR (KBr pellet, cm-1): 3132 m, 3090 w,
2970 w, 2920 m, 1561 s, 1456 s, 1411 s, 1380 s, 1301 s, 1259 s,
1155 w, 1109 m, 1041 s, 980 m, 905 m, 859 s, 795 m, 704 m, 635
w, 483 m. Insolubility precluded the recording of 1H NMR spectra.
[Y(Tpm*)(OTf)3‚THF], 2a. Tpm* (300 mg, 1.0 mmol) in THF
was added dropwise to a slightly turbid solution of Y(OTf)3 (540
mg, 1.0 mmol) in THF. A clear, pale-yellow solution was produced,
and stirring was continued overnight. The solution was filtered,
and the volume of THF was decreased under reduced pressure until
the product began to precipitate from solution. Precipitated product
was redissolved by warming the flask. The flask was then placed
inside a dewar and placed in a freezer at -20 °C overnight for
slow cooling. [Y(Tpm*)(OTf)3(THF)] formed as clear, flat crystals.
Yield: 370 mg (41%). Anal. Calcd for C23H30N6O10S3F9Y: C, 30.5;
H, 3.3; N, 9.3. Found: C, 29.9; H, 3.2; N, 9.5. IR (KBr pellet,
cm-1): 3150 w, 2998 m, 2938 m, 1570 m, 1460 m, 1424 m, 1328
s, 1208 s br, 1018 s, 911 w, 860 m, 804 w, 707 m, 633 s, 586 w,
512 m. 1H NMR (400 MHz, CD3CN, 293 K): δ 1.84 (m, 4H, THF),
2.43 (s, 9H, 3- or 5-Me), 2.59 (s, 9H, 3- or 5-Me), 3.67 (m, 4H,
THF), 6.16 (s, 3H, Tpm 4-CH), 7.96 (s, 1H, Tpm C-H).
[Ho(Tpm*)(OTf)3(THF)], 2b. The preparation of 2b was carried
out analogous to that of 2a using Tpm* (200 mg, 0.67 mmol) and
Ho(OTf)3 (410 mg, 0.67 mmol) in THF. [Ho(Tpm*)(OTf)3(THF)]
formed as clear crystals which desolvated upon removal of solvent.
Yield: 290 mg (45%). Anal. Calcd for C23H30N6O10S3F9Ho: C,
28.2; H, 3.1; N, 8.6. Found: C, 27.6; H, 3.1; N, 8.4. IR (KBr pellet,
cm-1): 3152 w, 2994 m, 2932 m, 1570 m, 1462 m, 1422 m, 1390
w, 1337 s, 1208 s br, 1021 s, 909 w, 861 m, 802 w, 707 m, 636 s,
586 w, 512 m. The compound was NMR silent.
[Dy(Tpm*)(OTf)3.THF], 2c. The preparation of 2c was carried
out analogous to that of 2a using Tpm* (130 mg, 0.44 mmol) and
Dy(OTf)3 (270 mg, 0.44 mmol). [Dy(Tpm*)(OTf)3‚THF] was
formed as flat, colorless crystals. Yield: 180 mg (42%). Anal. Calcd
for C23H30N6O10S3F9Dy: C, 28.2; H, 3.1; N, 8.6. Found: C, 27.8;
H, 3.0; N, 8.5. IR (KBr pellet, cm-1): 3145 w, 2996 m, 2930 m,
1569 m 1465 m, 1419 m, 1391 w, 1337 s, 1206 s br, 1187 s, 1019
s, 909 w, 861 m, 802 w, 767 w, 705 m, 636 s, 586 w, 511 m. The
compound was NMR silent.
[Nd(Tpm*)(OArMe2)3], 3b. The reaction was carried out analo-
gous to the procedure for 3a using NdCl3 (250 mg, 0.100 mmol),
Tpm* (290 mg, 0.100 mmol), and HOArMe2 (360 mg, 0.300 mmol).
After filtration, a light-greenish solution resulted from which light-
blue, block-like crystals of Nd(Tpm*)(OArMe2
) were obtained
3
which desolvated upon removal of solvent. Yield: 520 mg (69%).
Anal. Calcd for C40H49N6O3Nd: C, 59.6; H, 6.1; N, 10.4. Found:
C, 59.6; H, 6.2; N, 10.3. IR (KBr pellet, cm-1): 3135 w, 3108 w,
2920 s, 2855 s, 1600 w, 1563 m, 1475 s br, 1429 s, 1380 m, 1300
s, 1275 s, 1236 m, 1159 m, 1088 w, 1033 m, 978 w, 857 m, 820
1
s, 794 m sh, 721 m, 512 s. H NMR (CD2Cl2, 400 MHz, 204 K):
δ 0.34 (br s, 18H, Me-OAr), 0.49 (s, 9H, 5-Me), 2.62 (s, 1H,
Tpm C-H), 4.65 (br s, 9H, 3-Me), 6.72 (s, 3H, Tpm 4-CH), 6.91
(br t, J ) 5.1 Hz, 3H, p-H), 8.50 (br, 6H, m-H). 13C{1H} NMR
(CD2Cl2, 100.58 MHz, 293 K): δ 8.03 (3- or 5-Me), 11.76 (3- or
5-Me), 15.55 (OArMe), 64.55 (Tpm CH), 119.27 (Tpm 4-CH),
122.05 (p-OAr), 128.17 (m-OAr), 141.38 (br, 2-OAr), 146.08
(Tpm* qt), 151.65 (Tpm* qt), 210.95 (br, ipso-OAr).
[Sm(Tpm*)(OArMe2)3], 3c. The preparation of 3c was carried
out analogous to that of 3a using SmCl3 (150 mg, 0.57 mol), Tpm*
(170 mg, 0.57 mmol), and NaOArMe2 (250 mg, 1.88 mol). The dark-
orange solution of Sm(Tpm*)(OArMe2
) in THF was filtered to
3
remove the NaCl, and the volume of THF was reduced under
vacuum. The flask was placed in a Dewar flask and put in the
freezer for crystallization. After 2 days, large pale-orange crystals
of Sm(Tpm*)(OArMe2)3 had formed. Yield: 310 g (65%). Anal.
Calcd for C40H49N6O3Sm: C, 59.0; H, 6.1; N, 10.3. Found: C,
59.5; H, 6.5; N, 10.0. IR (KBr pellet, cm-1): 3140 w, 3105 w,
2923 s, 2852 s, 1606 w, 1568 m, 1475 s br, 1423 s, 1380 m, 1309
s, 1260 s, 1159 m, 1109 w, 1036 m, 956 w, 860 m, 818 s, 796 m
sh, 707 m, 509 s. 1H NMR (CD2Cl2, 300 MHz, 293 K): δ 1.22 (s,
18H, Me-OAr), 1.62 (s, 9H, 3-Me), 2.18 (s, 9H, 5-Me), 4.91 (s,
1H, Tpm C-H), 5.23 (s, 3H, p-H), 5.80 (s, 3H, Tpm 4-CH), 6.81
(s, 6H, m-H).
[Sm(Tpm*)(OArMe3)3], 3d. The preparation of 3d was carried
out analogous to that of 3c from SmCl3 (317 mg, 1.23 mmol).
Yield: 508 mg (48%). Anal. Calcd for C43H55N6O3Sm: C, 60.4;
H, 6.5; N, 9.8. Found: C, 60.0; H, 6.8; N, 9.6. IR (KBr pellet,
cm-1): 3135 w, 3112 m, 2925 s, 2892 s, 2848 s, 1610 w, 1562 m,
1475 s br, 1428 s, 1375 m, 1340 m, 1310 s, 1258 m, 1158 s, 1112
w, 1040 m, 960 w, 860 m, 835 w, 816 s, 795 m, 705 m, 500 s. 1H
NMR (CD2Cl2, 300 MHz, 293 K): δ 1.11 (s, 18H, o-Me), 1.65 (s,
9H, 3-Me), 2.23 (s, 9H, p-CH3), 4.93 (s, 9H, 5-Me), 4.97 (s, 1H,
Tpm C-H), 5.77 (s, 3H, Tpm 4-CH), 6.78 (s, 6H, m-H). 13C{1H}
NMR (CD2Cl2, 75.44 MHz, 293 K): δ 10.18 (3-Me), 17.62 (OAr-
o-Me), 17.72 (5-Me), 20.98 (OAr-p-Me), 62.10 (Tpm CH), 106.13
(Tpm 4-CH), 122.83 (p-OAr), 125.35 (o-OAr), 128.97 (m-OAr),
137.96 (Tpm* qt), 156.23 (Tpm* qt), 161.26 (br, ipso-OAr).
[Yb(Tpm*)(OArMe2)3], 3e. The preparation of 3e was carried
out analogous to that of 3a using YbCl3 (187 mg, 0.67 mmol),
Tpm* (200 mg, 0.67 mmol), and NaOArMe2 (245 mg, 2.0 mmol).
The pale-yellow solution yielded a mass of small, shiny crystals
upon cooling to -20 °C. These desolvated upon removal of solvent
and pumping to dryness to give a cream-colored powder. Yield:
[Y(Tpm*)(OArMe2)3], 3a. A turbid, white solution of YCl3 (150
mg, 0.77 mmol) in THF was stirred in a Schlenk flask. To this
was added dropwise a pale-yellow solution of Tpm* (230 mg, 0.77
mmol) to afford a yellow solution and a white precipitate. After
stirring for 2 h, NaOArMe2 (330 mg, 2.3 mmol) in THF (10 mL)
was added dropwise to the suspension with stirring. The white solid
dissolved during the addition of the aryloxide, and upon stirring
for 2-3 h further, a white precipitate of NaCl formed. The
suspension was allowed to settle overnight, and the salt was
removed by filtration. The volume of the filtrate was reduced to
10 mL, and the solution was placed in a freezer at -25 °C. After
ca. 48 h, [Y(Tpm*)(OArMe2)3] had formed as large, colorless
crystals. Yield: 470 mg (82%). Anal. Calcd for C40H49N6O3Y: C,
64.0; H, 6.6; N, 11.2. Found: C, 63.8; H, 6.7; N, 11.0. IR (KBr
pellet, cm-1): 3137 w, 3100 w, 3008 m, 2915 s, 2849 m, 1590 s,
1566 m, 1463 s, 1427 s, 1379 m, 1306 s, 1285 s, 1241 m, 1090 m,
1858 Inorganic Chemistry, Vol. 46, No. 5, 2007